Tag: Niraparib

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Niraparib

Ribon Raises $65M to Pursue PARP-Blocking Pills for Cancer

Added to Collection on: 2019-01-03 20:00:00

Tags for this article:

Medicine

Boston

Biology

Click the tags to see associated articles and topics

View Article Details

Niraparib maintenance therapy in patients with platinum-sensitive recurrent ovarian cancer using ...

Added to Collection on: 2021-01-18 05:15:00

Tags for this article:

Progression-free survival

Ovarian cancer

Click the tags to see associated articles and topics

View Article Details

Global Ovarian Cancer Drug Market Industry Outlook 2021-2026||F. Hoffmann-La Roche Ltd, Pfizer ...

Added to Collection on: 2021-01-25 16:42:51

Tags for this article:

Click the tags to see associated articles and topics

View Article Details

SMC endorses Alexion's Ultomiris

Added to Collection on: 2021-05-11 09:00:00

Tags for this article:

Atypical hemolytic uremic syndrome

Eculizumab

Niraparib

Hemolytic–uremic syndrome

Mycosis fungoides

Alexion

Click the tags to see associated articles and topics

View Article Details

Scotland backs NHS use of Alexion's Ultomiris for rare disease aHUS

Added to Collection on: 2021-05-11 08:15:00

Tags for this article:

Atypical hemolytic uremic syndrome

Eculizumab

Healthcare Improvement Scotland

Hemolytic–uremic syndrome

Niraparib

National Health Service

Soliris

Click the tags to see associated articles and topics

View Article Details

Pharmalittle: AstraZeneca sues Glaxo over a big-selling cancer drug; EU offers rival plan to Covid ...

Added to Collection on: 2021-06-07 13:18:45

Tags for this article:

Click the tags to see associated articles and topics

View Article Details

Illumina, Merck Partner to Advance Homologous Recombination Deficiency CDx, Research Assay

Added to Collection on: 2021-09-07 13:30:00

Tags for this article:

Molecular diagnostics

Illumina

Click the tags to see associated articles and topics

View Article Details

Metastatic Castration-Sensitive Prostate Cancer Market to Reach Upto USD 5.5 billion by 2032

Added to Collection on: 2022-06-20 16:18:51

Tags for this article:

Management of prostate cancer

Bristol-Myers Squibb

Prostate

Lutetium (177Lu) vipivotide tetraxetan

DelveInsight Business Research LLP

United States

Niraparib

Spain

Click the tags to see associated articles and topics

View Article Details

AstraZeneca's Lynparza to dominate PARP inhibitors market with $4 billion in sales by 2027 ...

Added to Collection on: 2024-04-24 13:11:58

Tags for this article:

Click the tags to see associated articles and topics

View Article Details

FoundationOne Liquid CDx Receives FDA Approval as a Diagnostic Tool for Patients With ...

Added to Collection on: 2024-07-02 16:15:42

Tags for this article:

Breast cancer

DNA repair

Tumor markers

Tumor suppressor genes

Click the tags to see associated articles and topics

View Article Details

Tag: Niraparib

Recent Related Articles to Niraparib

Ribon Raises $65M to Pursue PARP-Blocking Pills for Cancer

Niraparib maintenance therapy in patients with platinum-sensitive recurrent ovarian cancer using ...

Global Ovarian Cancer Drug Market Industry Outlook 2021-2026||F. Hoffmann-La Roche Ltd, Pfizer ...

SMC endorses Alexion's Ultomiris

Scotland backs NHS use of Alexion's Ultomiris for rare disease aHUS

Pharmalittle: AstraZeneca sues Glaxo over a big-selling cancer drug; EU offers rival plan to Covid ...

Illumina, Merck Partner to Advance Homologous Recombination Deficiency CDx, Research Assay

Metastatic Castration-Sensitive Prostate Cancer Market to Reach Upto USD 5.5 billion by 2032

AstraZeneca's Lynparza to dominate PARP inhibitors market with $4 billion in sales by 2027 ...

FoundationOne Liquid CDx Receives FDA Approval as a Diagnostic Tool for Patients With ...

Create dashboard for Tag: Niraparib